SCHEMBL1349546

SCHEMBL1349546

FC(F)(F)c1cccc(-c2cc(Cl)nnc2Cl)c1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 3/20 0.46
RORC P51449 3/20 0.46
RORB Q92753 3/20 0.46
HSD17B10 Q99714 2/20 0.46
MEN1 O00255 2/20 0.46
HPGD P15428 2/20 0.46
KMT2A Q03164 2/20 0.46
NPC1 O15118 1/20 0.46
ALDH1A1 P00352 1/20 0.46
CYP1A2 P05177 1/20 0.46
CYP3A4 P08684 1/20 0.46
THRB P10828 1/20 0.46
CYP2C9 P11712 1/20 0.46
PKM P14618 1/20 0.46
TSHR P16473 1/20 0.46
STAT6 P42226 1/20 0.46
HTT P42858 1/20 0.46
RAB9A P51151 1/20 0.46
SMN1; SMN2 Q16637 1/20 0.46
HIF1A Q16665 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1013642 0.81 CASP1 (0.47) KDM4EHSD17B10ALDH1A1CYP1A2DYRK1A
SCHEMBL27863432 0.79 NOTUM (0.48) KDM4ERORCRORBHSD17B10MEN1
SCHEMBL3024901 0.78 TDO2 (0.45) NPC1TSHRRAB9ASMN1; SMN2NOTUM
SCHEMBL9138126 0.77 ADORA2A (0.51) KDM4ERORCRORBHSD17B10MEN1
SCHEMBL3970891 0.75 CNR2 (0.53) KDM4ERORCRORBHSD17B10MEN1
SCHEMBL11624655 0.75 ADORA2A (0.49) KDM4ERORCRORBHSD17B10MEN1
SCHEMBL30041839 0.75 CYP2A6 (0.43) KDM4EMEN1HPGDKMT2ANPC1
SCHEMBL527009 0.75 CYP2A6 (0.43) KDM4EMEN1HPGDKMT2ANPC1
SCHEMBL12130901 0.75 RAB9A (0.42) HSD17B10MEN1HPGDKMT2ANPC1
SCHEMBL8740101 0.74 MAOB (0.52) KDM4ERORCRORBHSD17B10MEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 17 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2396337-B1 PREPARATION AND USE OF ZINC-AMIDES UNIV MUENCHEN LUDWIG MAXIMILIANS (DE) 2016-07-13 EP claimed
EP-2396337-A1 PRODUCTION AND USE OF ZINC AMIDES Ludwig-Maximilians-Universität München (DE) 2011-12-21 EP claimed
US-20110288296-A1 PRODUCTION AND USE OF ZINC AMIDES LUDWIG-MAXIMILIANS-UNIVERSITÄT MÜNCHEN (DE) 2011-11-24 US claimed
WO-2010092096-A1 PRODUCTION AND USE OF ZINC AMIDES LUDWIG-MAXIMILIANS-UNIVERSITÄT MÜNCHEN (DE) 2010-08-19 WO claimed
US-9688701-B2 Production and use of zinc amides LUDWIG-MAXIMILIANS-UNIVERSITAT MUNCHEN (DE) 2017-06-27 US disclosed
US-9688701-B2 Production and use of zinc amides LUDWIG-MAXIMILIANS-UNIVERSITAT MUNCHEN (DE) 2017-06-27 US disclosed
US-20160215000-A1 Production And Use Of Zinc Amides UNIV MUENCHEN LUDWIG MAXIMILIANS (DE) 2016-07-28 US disclosed
US-20160215000-A1 Production And Use Of Zinc Amides UNIV MUENCHEN LUDWIG MAXIMILIANS (DE) 2016-07-28 US disclosed
EP-2396337-B1 PREPARATION AND USE OF ZINC-AMIDES UNIV MUENCHEN LUDWIG MAXIMILIANS (DE) 2016-07-13 EP disclosed
EP-2396337-B1 PREPARATION AND USE OF ZINC-AMIDES UNIV MUENCHEN LUDWIG MAXIMILIANS (DE) 2016-07-13 EP disclosed
US-9334237-B2 Production and use of zinc amides LUDWIG-MAXIMILIANS-UNIVERSITAT MUNCHEN (DE) 2016-05-10 US disclosed
US-9334237-B2 Production and use of zinc amides LUDWIG-MAXIMILIANS-UNIVERSITAT MUNCHEN (DE) 2016-05-10 US disclosed
CN-102395593-B Preparation and use of zinc amides LUDWIG-MAXIMILIANS-UNIVERSITAT MUNCHEN (DE) 2015-08-12 CN disclosed
EP-2396337-A1 PRODUCTION AND USE OF ZINC AMIDES Ludwig-Maximilians-Universität München (DE) 2011-12-21 EP disclosed
US-20110288296-A1 PRODUCTION AND USE OF ZINC AMIDES LUDWIG-MAXIMILIANS-UNIVERSITÄT MÜNCHEN (DE) 2011-11-24 US disclosed
WO-2010092096-A1 PRODUCTION AND USE OF ZINC AMIDES LUDWIG-MAXIMILIANS-UNIVERSITÄT MÜNCHEN (DE) 2010-08-19 WO disclosed
WO-2010092096-A1 PRODUCTION AND USE OF ZINC AMIDES LUDWIG-MAXIMILIANS-UNIVERSITÄT MÜNCHEN (DE) 2010-08-19 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20160215000-A1 Production And Use Of Zinc Amides SCLY, CBR3, SCO2 KDM4E 2931/4885RORC 3342/4885RORB 2491/4885
US-20110288296-A1 PRODUCTION AND USE OF ZINC AMIDES GLRX3, SCLY, SFXN1 KDM4E 3350/4885RORC 1862/4885RORB 1037/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.